Session » Abstracts: SLE – Diagnosis, Manifestations, & Outcomes II: Omics
- 4:00PM-5:30PM
-
Abstract Number: 1693
Blood Immunophenotyping Distinguishes Three Subgroups of Lupus Nephritis Patients with Distinct Kidney Infiltrates and Interferon Signatures
- 4:00PM-5:30PM
-
Abstract Number: 1698
High-throughput Proteomics Identities a Spectrum of Novel Serum Biomarkers of Lupus Nephritis
- 4:00PM-5:30PM
-
Abstract Number: 1697
Molecular Characterisation of Remission and Lupus Low Disease Activity State (LLDAS) by Whole-Blood Transcriptome-Based Pathways in a Pan-European Systemic Lupus Erythematosus Cohort
- 4:00PM-5:30PM
-
Abstract Number: 1696
Multi-Omic Profiling Reveals Immune Cell Priming Signature Linked to Systemic Lupus Erythematosus Prognosis
- 4:00PM-5:30PM
-
Abstract Number: 1695
Single Cell Transcriptomics in Kidney Tissue from African American Patients Enrolled in the Accelerating Medicines Partnership (AMP) Implicates Tubular Cells in the Pathogenesis of APOL1 Associated Lupus Nephritis
- 4:00PM-5:30PM
-
Abstract Number: 1694
Transcriptomic Analysis of the Impact of Iberdomide on Patients with SLE